Trial intelligence / Profile preview

Lauromacrogol 400 Foam Sclerotherapy for GSV Insufficiency

NCT00348764Phase 3Completed

Sponsor
CHU Grenoble Alpes
Start
Mar 2004
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of polidocanol in chronic venous insufficiency (CVI), sponsored by CHU Grenoble Alpes. Started Mar 2004; status: completed.

02

Drugs

polidocanol
03

Conditions

chronic venous insufficiency (CVI)

Beyond the preview

Go deeper on NCT00348764.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00348764.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call